Digitalis: reappraisal of its use after acute myocardial infarction.
D000208:Acute Disease; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D006332:Cardiomegaly / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004285:Dogs; D004341:Drug Evaluation; D004594:Electrophysiology; D004734:Energy Metabolism / Q000187:drug effects; D005260:Female; D006321:Heart / Q000502:physiology; D006329:Heart Conduction System / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy*; D010101:Oxygen Consumption / Q000187:drug effects; D011188:Potassium / Q000037:antagonists & inhibitors; D012770:Shock, Cardiogenic / Q000188:drug therapy; D012964:Sodium / Q000037:antagonists & inhibitors; D014655:Vascular Resistance / Q000187:drug effects
D004071:Digitalis Glycosides; D012964:Sodium; D011188:Potassium